发明申请
US20110053199A1 UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS
审中-公开
UBIQUITIN PROTEASOME系统分析及其在临床应用中的应用癌症诊断
- 专利标题： UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS
- 专利标题（中）： UBIQUITIN PROTEASOME系统分析及其在临床应用中的应用癌症诊断
-
申请号： US12861683申请日： 2010-08-23
-
公开(公告)号： US20110053199A1公开(公告)日： 2011-03-03
- 发明人: Maher Albitar , Wanlong Ma , Ke Zhang , Xi Zhang , Xiuqiang Wang , Kevin Qu , Anthony Sferruzza
- 申请人： Maher Albitar , Wanlong Ma , Ke Zhang , Xi Zhang , Xiuqiang Wang , Kevin Qu , Anthony Sferruzza
- 专利权人： Quest Diagnostics Investments Incorporated
- 当前专利权人： Quest Diagnostics Investments Incorporated
- 主分类号： C12Q1/37
- IPC分类号： C12Q1/37
摘要：
Provided herein are methods for the diagnosis, prognosis, or management of neoplastic diseases, i.e. cancer, and other diseases using profiles of the ubiquitin-protcasome system determined from acellular body fluids or cell-containing samples. Further provided are methods of predicting response to therapy in certain populations of cancer patients.
信息查询
